Dear VisitorBanyan Biomarkers has been acquired by bioMérieux, a global company specializing in in vitro diagnostics and infectious diseases. For more information about Banyan Biomarkers please refer to the contact page or contact bioMérieux directly.
"Pioneer the innovation, development, and commercialization of biomarkers to accurately and quickly diagnose traumatic brain injuries."
Manage patients with a test based on data and not subjective interpretation
Improve Patient Outcomes
Identify and triage patients that need additional medical assistance
Reduce radiation exposure from unnecessary CT scans